NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $329,573 | -89.9% | 20,407 | -74.0% | 0.01% | -89.8% |
| Q2 2023 | $3,251,691 | -37.9% | 78,354 | -10.0% | 0.06% | -43.8% |
| Q1 2023 | $5,236,089 | -13.0% | 87,065 | +6.2% | 0.10% | -19.2% |
| Q4 2022 | $6,015,434 | -6.1% | 82,010 | -2.8% | 0.13% | -9.1% |
| Q3 2022 | $6,408,000 | -23.2% | 84,344 | -29.7% | 0.14% | +23.3% |
| Q2 2022 | $8,341,000 | -16.4% | 120,020 | -0.3% | 0.12% | +3.6% |
| Q1 2022 | $9,976,000 | -13.4% | 120,416 | -21.5% | 0.11% | +4.7% |
| Q4 2021 | $11,514,000 | -31.4% | 153,357 | +6.2% | 0.11% | -34.0% |
| Q3 2021 | $16,776,000 | -49.2% | 144,410 | -2.9% | 0.16% | -44.9% |
| Q2 2021 | $33,006,000 | +109.4% | 148,798 | +24.8% | 0.29% | +101.4% |
| Q1 2021 | $15,765,000 | -26.3% | 119,271 | -3.6% | 0.15% | -26.3% |
| Q4 2020 | $21,398,000 | +61.8% | 123,662 | +4.1% | 0.20% | +35.6% |
| Q3 2020 | $13,229,000 | +225.4% | 118,844 | +73.4% | 0.15% | +192.0% |
| Q2 2020 | $4,065,000 | +12.0% | 68,548 | +27.2% | 0.05% | -18.0% |
| Q1 2020 | $3,629,000 | – | 53,885 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |